211 related articles for article (PubMed ID: 12917785)
1. Matrix metalloproteinases and endometriosis.
Osteen KG; Yeaman GR; Bruner-Tran KL
Semin Reprod Med; 2003 May; 21(2):155-64. PubMed ID: 12917785
[TBL] [Abstract][Full Text] [Related]
2. [Matrix metalloproteinases and their role in menstruation and endometriosis].
Hudelist G; Singer CF; Keckstein J
Zentralbl Gynakol; 2005 Oct; 127(5):320-4. PubMed ID: 16195977
[TBL] [Abstract][Full Text] [Related]
3. The role of matrix metalloproteinases in the pathogenesis of endometriosis.
Pitsos M; Kanakas N
Reprod Sci; 2009 Aug; 16(8):717-26. PubMed ID: 19351962
[TBL] [Abstract][Full Text] [Related]
4. Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis.
Osteen KG; Bruner-Tran KL; Eisenberg E
Fertil Steril; 2005 Mar; 83(3):529-37. PubMed ID: 15749474
[TBL] [Abstract][Full Text] [Related]
5. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.
Braundmeier AG; Nowak RA
Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716
[TBL] [Abstract][Full Text] [Related]
6. Progesterone-mediated endometrial maturation limits matrix metalloproteinase (MMP) expression in an inflammatory-like environment: a regulatory system altered in endometriosis.
Osteen KG; Bruner-Tran KL; Keller NR; Eisenberg E
Ann N Y Acad Sci; 2002 Mar; 955():37-47; discussion 86-8, 396-406. PubMed ID: 11949963
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases and their tissue inhibitors in the developing neonatal mouse uterus.
Hu J; Zhang X; Nothnick WB; Spencer TE
Biol Reprod; 2004 Nov; 71(5):1598-604. PubMed ID: 15240428
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting MMP activity prevents the development of endometriosis in the chicken chorioallantoic membrane model.
Nap AW; Dunselman GA; de Goeij AF; Evers JL; Groothuis PG
Hum Reprod; 2004 Oct; 19(10):2180-7. PubMed ID: 15242997
[TBL] [Abstract][Full Text] [Related]
9. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration.
Gaide Chevronnay HP; Selvais C; Emonard H; Galant C; Marbaix E; Henriet P
Biochim Biophys Acta; 2012 Jan; 1824(1):146-56. PubMed ID: 21982799
[TBL] [Abstract][Full Text] [Related]
10. The role of endometrium in endometriosis.
Ulukus M; Cakmak H; Arici A
J Soc Gynecol Investig; 2006 Oct; 13(7):467-76. PubMed ID: 16990031
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
Visse R; Nagase H
Circ Res; 2003 May; 92(8):827-39. PubMed ID: 12730128
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of endometriosis.
Nap AW; Groothuis PG; Demir AY; Evers JL; Dunselman GA
Best Pract Res Clin Obstet Gynaecol; 2004 Apr; 18(2):233-44. PubMed ID: 15157640
[TBL] [Abstract][Full Text] [Related]
13. Stable inhibition of interleukin 1 receptor type II in Ishikawa cells augments secretion of matrix metalloproteinases: possible role in endometriosis pathophysiology.
Guay S; Akoum A
Reproduction; 2007 Sep; 134(3):525-34. PubMed ID: 17709570
[TBL] [Abstract][Full Text] [Related]
14. The bimodal role of matrix metalloproteinases and their inhibitors in etiology and pathogenesis of endometriosis (Review).
Bałkowiec M; Maksym RB; Włodarski PK
Mol Med Rep; 2018 Sep; 18(3):3123-3136. PubMed ID: 30066912
[TBL] [Abstract][Full Text] [Related]
15. Paracrine mediators of endometrial matrix metalloproteinase expression: potential targets for progestin-based treatment of endometriosis.
Osteen KG; Bruner-Tran KL; Ong D; Eisenberg E
Ann N Y Acad Sci; 2002 Mar; 955():139-46; discussion 157-8, 396-406. PubMed ID: 11949943
[TBL] [Abstract][Full Text] [Related]
16. Trimegestone differentially modulates the expression of matrix metalloproteinases in the endometrial stromal cell.
Wahab M; Taylor AH; Pringle JH; Thompson J; Al-Azzawi F
Mol Hum Reprod; 2006 Mar; 12(3):157-67. PubMed ID: 16556677
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
[TBL] [Abstract][Full Text] [Related]
18. Expression of membrane-type 5 matrix metalloproteinase in human endometrium and endometriosis.
Gaetje R; Holtrich U; Engels K; Kourtis K; Cikrit E; Kissler S; Rody A; Karn T; Kaufmann M
Gynecol Endocrinol; 2007 Oct; 23(10):567-73. PubMed ID: 17952761
[TBL] [Abstract][Full Text] [Related]
19. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.
Baum O; Ganster M; Baumgartner I; Nieselt K; Djonov V
J Vasc Res; 2007; 44(3):202-13. PubMed ID: 17337906
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
Gueders MM; Foidart JM; Noel A; Cataldo DD
Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
